Вплив магнію на запобігання розвитку фетоплацентарної недостатності

Abstract

Maternal hypomagnesaemia during pregnancy may increase the risk of threatened miscarriage, fetal growth retardation, gestational diabetes mellitus,preeclampsia. The paper analyzes the effectiveness of the use of magnesium to prevent the development of fetoplacental insufficiency. For this purpose, the hemodynamics of the uteroplacental and fetal circulation was evaluated before and after the use of magnesium preparations in pregnant women in the 2nd trimester of pregnancy. The dependence of the development of FPI on magnesium deficiency in the body was revealed. The most effective methods for preventing the development of this pathology have been proposed.